BELLA: A Phase 2 Study of Relacorilant + Nab-Paclitaxel +/- Bevacizumab in Patients with Gynecologic Cancers

Presented: Society of Gynecologic Oncology, 12 April 2026, San Juan, Puerto Rico

Presenter: Jae-Weon Kim, M.D., Ph.D.

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.